𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of efficacy of imatinib in a patient with metastatic Leydig cell tumor

✍ Scribed by Michael Froehner; Bettina Beuthien-Baumann; Dag-Daniel Dittert; Ulrich Schuler; Manfred P. Wirth

Book ID
105992310
Publisher
Springer
Year
2006
Tongue
English
Weight
293 KB
Volume
58
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Resection of residual disease in patient
Resection of residual disease in patients with metastatic gastrointestinal stromal tumors responding to treatment with imatinib
✍ Sebastian Bauer; JΓΆrg Thomas Hartmann; Maike de Wit; Hauke Lang; Florian Grabell πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 French βš– 723 KB

## Abstract Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. Long‐term survival of patients with metastatic disease has only been observed in patients with completely resected disease. Recently, the tyrosine kinase inhibitor imatinib has b